Symbols / RVPH Stock $0.72 -11.08% Reviva Pharmaceuticals Holdings, Inc.

Healthcare • Biotechnology • United States • NCM
RVPH (Stock) Chart
About

Reviva Pharmaceuticals Holdings, Inc., a biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, inflammatory, and cardiometabolic diseases. The company's lead product candidate comprises brilaroxazine (RP5063) for the treatment of neuropsychiatric indications, including schizophrenia, bipolar disorder, major depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia and Alzheimer's disease, and Parkinson's disease psychosis; in clinical development for respiratory indications, such as pulmonary arterial hypertension and idiopathic pulmonary fibrosis; and in preclinical development for the treatment of psoriasis. It is also developing RP1208 for the treatment of depression and obesity. The company was founded in 2018 and is headquartered in Cupertino, California.

Fundamentals
Scroll to Statements
Sector Healthcare Industry Biotechnology Market Cap 9.22M
Enterprise Value -4.81M Income -19.86M Sales —
Book/sh 1.47 Cash/sh 1.13 Dividend Yield —
Payout 0.00% Employees 14 IPO —
P/E — Forward P/E -0.87 PEG —
P/S — P/B 0.49 P/C —
EV/EBITDA — EV/Sales — Quick Ratio 1.99
Current Ratio 2.08 Debt/Eq 4.71 LT Debt/Eq —
EPS (ttm) -5.48 EPS next Y -0.82 EPS Growth —
Revenue Growth — Earnings 2026-05-14 ROA -80.35%
ROE -4.20% ROIC — Gross Margin 0.00%
Oper. Margin 0.00% Profit Margin 0.00% Shs Outstand 12.81M
Shs Float 11.21M Short Float 14.39% Short Ratio 3.87
Short Interest — 52W High 23.20 52W Low 0.59
Beta 0.64 Avg Volume 473.90K Volume 2.04M
Target Price $51.83 Recom Strong_buy Prev Close $0.81
Price $0.72 Change -11.08%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$51.83
Mean price target
2. Current target
$0.72
Latest analyst target
3. DCF / Fair value
$-24.08
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.72
Low
$1.00
High
$140.00
Mean
$51.83

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-03-05 down D. Boral Capital Buy → Hold —
2026-01-05 main Chardan Capital Buy → Buy $2
2025-12-23 main D. Boral Capital Buy → Buy $2
2025-12-23 reit HC Wainwright & Co. Buy → Buy $4
2025-11-19 main D. Boral Capital Buy → Buy $2
2025-10-28 main D. Boral Capital Buy → Buy $2
2025-10-27 main HC Wainwright & Co. Buy → Buy $4
2025-09-29 init Chardan Capital — → Buy $2
2025-09-19 main D. Boral Capital Buy → Buy $2
2025-09-15 main Benchmark Speculative Buy → Speculative Buy $7
2025-08-18 reit Roth Capital Buy → Buy $3
2025-08-18 main D. Boral Capital Buy → Buy $3
2025-08-15 main Maxim Group Buy → Buy $2
2025-06-27 main D. Boral Capital Buy → Buy $3
2025-06-03 main D. Boral Capital Buy → Buy $3
2025-05-20 main D. Boral Capital Buy → Buy $3
2025-04-24 main D. Boral Capital Buy → Buy $8
2025-04-01 main D. Boral Capital Buy → Buy $8
2025-01-22 main HC Wainwright & Co. Buy → Buy $11
2025-01-21 main D. Boral Capital Buy → Buy $15
Insider Transactions

No recent insider transactions.

Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
0.00
0.00
0.00
0.00
Operating Revenue
0.00
0.00
0.00
0.00
Operating Expense
20.20
-34.41%
30.80
-22.04%
39.50
+39.94%
28.23
Research And Development
11.71
-48.89%
22.91
-27.09%
31.42
+37.38%
22.87
Selling General And Administration
8.49
+7.60%
7.89
-2.38%
8.08
+50.85%
5.36
General And Administrative Expense
8.49
+7.60%
7.89
-2.38%
8.08
+50.85%
5.36
Other Gand A
8.49
+7.60%
7.89
-2.38%
8.08
+50.85%
5.36
Total Expenses
20.20
-34.41%
30.80
-22.04%
39.50
+39.94%
28.23
Operating Income
-20.20
+34.41%
-30.80
+22.04%
-39.50
-39.94%
-28.23
Total Operating Income As Reported
-20.20
+34.41%
-30.80
+22.04%
-39.50
-39.94%
-28.23
EBITDA
-19.83
+33.63%
-29.88
+23.79%
-39.21
-38.90%
-28.23
Normalized EBITDA
-19.92
+34.89%
-30.60
+21.48%
-38.97
-39.01%
-28.03
Reconciled Depreciation
—
—
—
—
EBIT
-19.83
+33.63%
-29.88
+23.79%
-39.21
-38.90%
-28.23
Total Unusual Items
0.09
-87.60%
0.72
+400.00%
-0.24
-22.86%
-0.19
Total Unusual Items Excluding Goodwill
0.09
-87.60%
0.72
+400.00%
-0.24
-22.86%
-0.19
Net Income
-19.86
+33.60%
-29.92
+23.79%
-39.26
-38.92%
-28.26
Pretax Income
-19.85
+33.62%
-29.90
+23.81%
-39.24
-38.96%
-28.24
Net Non Operating Interest Income Expense
0.30
-13.10%
0.34
-5.98%
0.36
+99.50%
0.18
Interest Expense Non Operating
0.01
-27.55%
0.02
-45.15%
0.03
—
Net Interest Income
0.30
-13.10%
0.34
-5.98%
0.36
+99.50%
0.18
Interest Expense
0.01
-27.55%
0.02
-45.15%
0.03
—
Interest Income Non Operating
0.31
-13.84%
0.36
-9.30%
0.40
+117.95%
0.18
Interest Income
0.31
-13.84%
0.36
-9.30%
0.40
+117.95%
0.18
Other Income Expense
0.06
-89.93%
0.56
+630.52%
-0.10
+46.10%
-0.19
Other Non Operating Income Expenses
-0.03
+79.52%
-0.16
-219.84%
0.13
—
Gain On Sale Of Security
0.09
-87.60%
0.72
+400.00%
-0.24
-22.86%
-0.19
Tax Provision
0.02
-3.20%
0.02
+15.13%
0.02
-18.42%
0.02
Tax Rate For Calcs
0.00
+0.00%
0.00
+0.00%
0.00
+0.00%
0.00
Tax Effect Of Unusual Items
0.02
-87.60%
0.15
+400.00%
-0.05
-22.86%
-0.04
Net Income Including Noncontrolling Interests
-19.86
+33.60%
-29.92
+23.79%
-39.26
-38.92%
-28.26
Net Income From Continuing Operation Net Minority Interest
-19.86
+33.60%
-29.92
+23.79%
-39.26
-38.92%
-28.26
Net Income From Continuing And Discontinued Operation
-19.86
+33.60%
-29.92
+23.79%
-39.26
-38.92%
-28.26
Net Income Continuous Operations
-19.86
+33.60%
-29.92
+23.79%
-39.26
-38.92%
-28.26
Normalized Income
-19.94
+34.61%
-30.49
+21.98%
-39.07
-39.01%
-28.11
Net Income Common Stockholders
-19.86
+33.60%
-29.92
+23.79%
-39.26
-38.92%
-28.26
Diluted EPS
—
-18.00
+45.45%
-33.00
-32.00%
-25.00
Basic EPS
—
-18.00
+45.45%
-33.00
-32.00%
-25.00
Basic Average Shares
—
1.66
+39.29%
1.19
+21.94%
0.98
Diluted Average Shares
—
1.66
+39.29%
1.19
+21.94%
0.98
Diluted NI Availto Com Stockholders
-19.86
+33.60%
-29.92
+23.79%
-39.26
-38.92%
-28.26
Total Other Finance Cost
—
—
—
-0.18
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
15.92
+2.71%
15.50
-34.59%
23.70
+25.24%
18.92
Current Assets
15.10
+2.86%
14.68
-38.05%
23.70
+25.24%
18.92
Cash Cash Equivalents And Short Term Investments
14.44
+7.14%
13.48
-42.33%
23.37
+26.18%
18.52
Cash And Cash Equivalents
14.44
+7.14%
13.48
-42.33%
23.37
+26.18%
18.52
Cash Equivalents
13.23
+8.40%
12.20
-45.06%
22.21
—
Cash Financial
1.21
-4.92%
1.27
+10.13%
1.16
—
Prepaid Assets
0.00
-100.00%
0.54
+590.47%
0.08
-80.61%
0.40
Other Current Assets
0.66
-0.26%
0.67
+161.72%
0.25
-36.94%
0.40
Total Non Current Assets
0.82
+0.00%
0.82
0.00
0.00
Non Current Prepaid Assets
0.82
+0.00%
0.82
0.00
—
Total Liabilities Net Minority Interest
7.28
-50.47%
14.69
-18.30%
17.98
+70.78%
10.53
Current Liabilities
7.28
-50.17%
14.60
-14.98%
17.18
+72.41%
9.96
Payables And Accrued Expenses
6.38
-52.75%
13.51
-16.70%
16.22
+72.56%
9.40
Payables
3.01
-52.11%
6.28
+63.24%
3.85
+9.34%
3.52
Accounts Payable
3.01
-52.11%
6.28
+63.24%
3.85
+9.34%
3.52
Current Accrued Expenses
3.37
-53.30%
7.22
-41.59%
12.37
+110.43%
5.88
Pensionand Other Post Retirement Benefit Plans Current
0.49
-23.55%
0.64
-33.70%
0.96
+69.77%
0.56
Current Debt And Capital Lease Obligation
0.41
-11.19%
0.46
—
—
Current Debt
0.41
-11.19%
0.46
—
—
Other Current Borrowings
0.41
-11.19%
0.46
—
—
Total Non Current Liabilities Net Minority Interest
0.00
-100.00%
0.09
-88.97%
0.81
+42.16%
0.57
Stockholders Equity
8.65
+964.23%
0.81
-85.79%
5.72
-31.87%
8.39
Common Stock Equity
8.65
+964.23%
0.81
-85.79%
5.72
-31.87%
8.39
Capital Stock
0.01
+150.21%
0.00
+66.83%
0.00
+36.53%
0.00
Common Stock
0.01
+150.21%
0.00
+66.83%
0.00
+36.53%
0.00
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
5.87
+152.17%
2.33
+66.84%
1.40
+36.54%
1.02
Ordinary Shares Number
5.87
+152.17%
2.33
+66.84%
1.40
+36.54%
1.02
Additional Paid In Capital
192.77
+16.78%
165.08
+17.86%
140.07
+35.35%
103.49
Retained Earnings
-184.14
-12.09%
-164.27
-22.27%
-134.35
-41.29%
-95.09
Total Equity Gross Minority Interest
8.65
+964.23%
0.81
-85.79%
5.72
-31.87%
8.39
Total Capitalization
8.65
+964.23%
0.81
-85.79%
5.72
-31.87%
8.39
Working Capital
7.83
+9462.46%
0.08
-98.75%
6.53
-27.19%
8.96
Invested Capital
9.05
+612.55%
1.27
-77.78%
5.72
-31.87%
8.39
Total Debt
0.41
-11.19%
0.46
—
—
Net Tangible Assets
8.65
+964.23%
0.81
-85.79%
5.72
-31.87%
8.39
Tangible Book Value
8.65
+964.23%
0.81
-85.79%
5.72
-31.87%
8.39
Derivative Product Liabilities
0.00
-100.00%
0.09
-88.97%
0.81
+42.16%
0.57
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-24.59
+26.68%
-33.54
-18.43%
-28.32
-49.39%
-18.96
Cash Flow From Continuing Operating Activities
-24.59
+26.68%
-33.54
-18.43%
-28.32
-49.39%
-18.96
Net Income From Continuing Operations
-19.86
+33.60%
-29.92
+23.79%
-39.26
-38.92%
-28.26
Depreciation Amortization Depletion
—
—
—
—
Depreciation
—
—
—
—
Depreciation And Amortization
—
—
—
—
Other Non Cash Items
—
—
—
—
Stock Based Compensation
2.23
+36.65%
1.63
-52.24%
3.41
+1831.34%
0.18
Operating Gains Losses
-0.09
+87.60%
-0.72
-400.00%
0.24
+22.86%
0.19
Gain Loss On Investment Securities
-0.09
+87.60%
-0.72
-400.00%
0.24
+22.86%
0.19
Change In Working Capital
-6.87
-51.36%
-4.54
-162.30%
7.28
-18.43%
8.93
Change In Prepaid Assets
0.54
+132.02%
-1.69
-2489.47%
0.07
-94.60%
1.31
Change In Payables And Accrued Expense
-7.41
-160.58%
-2.84
-139.43%
7.21
-5.31%
7.62
Change In Accrued Expense
-4.00
+22.04%
-5.14
-174.59%
6.88
+49.45%
4.61
Change In Payable
-3.41
-248.73%
2.29
+596.75%
0.33
-89.08%
3.01
Change In Account Payable
-3.41
-248.73%
2.29
+596.75%
0.33
-89.08%
3.01
Financing Cash Flow
25.56
+8.05%
23.65
-28.70%
33.17
+325.69%
7.79
Cash Flow From Continuing Financing Activities
25.56
+8.05%
23.65
-28.70%
33.17
+325.69%
7.79
Net Issuance Payments Of Debt
-0.05
-111.19%
0.46
0.00
0.00
Issuance Of Debt
0.41
-58.35%
0.98
+46.35%
0.67
0.00
Repayment Of Debt
-0.46
+11.68%
-0.52
+22.28%
-0.67
0.00
Long Term Debt Issuance
—
—
—
—
Net Long Term Debt Issuance
—
—
—
—
Short Term Debt Issuance
0.41
-58.35%
0.98
+46.35%
0.67
0.00
Short Term Debt Payments
-0.46
+11.68%
-0.52
+22.28%
-0.67
0.00
Net Short Term Debt Issuance
-0.05
-111.19%
0.46
0.00
0.00
Net Common Stock Issuance
18.63
-19.67%
23.19
-15.64%
27.49
+253.69%
7.77
Proceeds From Stock Option Exercised
6.98
+4681822.82%
0.00
-100.00%
5.68
+29836.99%
0.02
Changes In Cash
0.96
+109.73%
-9.89
-304.04%
4.85
+143.41%
-11.17
Beginning Cash Position
13.48
-42.33%
23.37
+26.18%
18.52
-37.62%
29.69
End Cash Position
14.44
+7.14%
13.48
-42.33%
23.37
+26.18%
18.52
Free Cash Flow
-24.59
+26.68%
-33.54
-18.43%
-28.32
-49.39%
-18.96
Interest Paid Supplemental Data
0.01
-27.55%
0.02
-39.60%
0.03
0.00
Income Tax Paid Supplemental Data
0.00
-1.40%
0.00
-82.70%
0.02
+19.84%
0.02
Change In Interest Payable
—
—
—
—
Common Stock Issuance
18.63
-19.67%
23.19
-15.64%
27.49
+253.69%
7.77
Issuance Of Capital Stock
18.63
-19.67%
23.19
-15.64%
27.49
+253.69%
7.77
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category